Kiromic BioPharma, Inc.
KRBPQ
$0.0615
-$0.083-57.44%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -26.90M | -25.10M | -21.86M | -21.80M | -20.95M |
| Total Depreciation and Amortization | 2.23M | 2.22M | 2.23M | 2.22M | 2.22M |
| Total Amortization of Deferred Charges | -- | -- | -445.00K | -79.00K | 0.00 |
| Total Other Non-Cash Items | 5.01M | 2.88M | 2.58M | 2.57M | 2.51M |
| Change in Net Operating Assets | 198.00K | -1.22M | -7.02M | -5.71M | -5.01M |
| Cash from Operations | -19.46M | -21.22M | -24.52M | -22.80M | -21.23M |
| Capital Expenditure | -366.00K | -447.00K | -326.00K | -228.00K | -207.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -366.00K | -447.00K | -326.00K | -228.00K | -207.00K |
| Total Debt Issued | 18.90M | 20.80M | 26.88M | 24.40M | 24.00M |
| Total Debt Repaid | -485.00K | -457.00K | -532.00K | -602.00K | -557.00K |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 659.00K | 659.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.00K | -29.00K | 189.00K | -111.00K |
| Cash from Financing | 18.42M | 20.34M | 26.32M | 24.65M | 23.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.41M | -1.32M | 1.48M | 1.62M | 2.56M |